Get the app
US › Healthcare

Spruce Biosciences, Inc. Common Stock (SPRB)

US · Healthcare · Biotechnology

$53.86-0.55%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-16.2M
EPS
$-6.68
EPS estimate
$-4.79

EPS came in at -6.68 against a street estimate of -4.79 — a miss of 39.5%.

Key statistics

Market cap
$154.3M
Forward P/E
0.0
P/B
1.84
Book value
$30.42
EPS (TTM)
$-38.43
52-week high
$240.00
52-week low
$7.26
50-day MA
$50.46
200-day MA
$62.59
Beta
3.36

Analyst view

Analysts rate Spruce Biosciences, Inc. Common Stock a hold (0 buy, 5 hold, 0 sell out of 5) with an average price target of $147.88.

Shareholding

Insiders
3.37%
Institutions
76.74%

Largest institutional holders

FundStake
AIGH Capital Management, LLC8.70%
Millennium Management LLC5.60%
Ikarian Capital, LLC4.22%
ADAR1 Capital Management LLC2.04%
Citadel Advisors Llc1.81%
Alyeska Investment Group, L.P.1.80%
BOOTHBAY FUND MANAGEMENT, LLC1.46%
Eversept Partners, LP1.39%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Spruce Biosciences, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.